+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Protein a Resin Market by Type, Application, End User, Product Form, Distribution Channel, Purity - Global Forecast to 2030- Product Image
Protein a Resin Market by Type, Application, End User, Product Form, Distribution Channel, Purity - Global Forecast to 2030- Product Image
Sale

Protein a Resin Market by Type, Application, End User, Product Form, Distribution Channel, Purity - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5635437
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Protein A Resin Market grew from USD 1.61 billion in 2024 to USD 1.82 billion in 2025. It is expected to continue growing at a CAGR of 13.27%, reaching USD 3.40 billion by 2030.

Defining the Evolution of Protein A Resin Market Dynamics

Protein A resin has become indispensable in downstream bioprocessing, serving as the gold standard for monoclonal antibody purification and other protein capture workflows. Its high specificity, binding capacity, and reusability have cemented its role in both therapeutic manufacturing and diagnostic development. As the biopharmaceutical industry continues its rapid expansion, advances in Protein A ligand design and resin matrix technologies are driving performance improvements across yield, purity, and cycle time.

The growing pipeline of biologics-including monoclonal antibodies, fusion proteins, and recombinant constructs-has amplified demand for robust purification platforms. Manufacturers are seeking scalable solutions that balance cost efficiency with stringent quality requirements. In parallel, smaller research entities and academic centers are adopting Protein A resins for early-stage process development, reflecting the technology’s versatility and reliability.

This executive summary synthesizes key trends, regulatory influences, market segmentation, regional dynamics, competitor strategies, and actionable recommendations. It provides a concise yet comprehensive overview of the current Protein A resin landscape, equipping decision-makers with the insights needed to navigate a complex and evolving marketplace.

Emerging Forces Redefining the Protein A Resin Ecosystem

The Protein A resin ecosystem is undergoing transformative shifts fueled by technology, regulation, and market demand. Continuous chromatography platforms are gaining traction, challenging traditional batch processes by offering higher throughput, lower resin inventories, and streamlined operations. Advances in ligand engineering have produced next-generation resins with improved acid stability and base resistance, extending reusability and reducing total cost of ownership.

Regulatory agencies are promoting process intensification and quality by design principles, encouraging biomanufacturers to adopt high-efficiency purification schemes. Sustainability considerations are also influencing resin selection, as companies pursue greener chemistries, reduced buffer consumption, and recyclable sorbents. Digitalization of bioprocess analytics, including real-time monitoring and predictive maintenance, is enhancing resin lifespan management and minimizing downtime.

Meanwhile, novel expression systems and emerging therapeutic modalities-such as bispecific antibodies and antibody-drug conjugates-are driving demand for specialized resin chemistries. The convergence of these forces is redefining competitive positioning, pushing established suppliers to innovate while opening opportunities for niche players focused on customized solutions.

Assessing the Cumulative Impact of United States Tariffs on Protein A Resin in 2025

In 2025, the cumulative impact of United States import tariffs is reshaping supply chains and pricing strategies within the Protein A resin market. Escalating duties on select raw materials and finished goods have increased landed costs, compelling companies to re-evaluate sourcing and buffer inventory strategies. Suppliers dependent on overseas manufacturing have absorbed certain tariff burdens while passing incremental costs to end users.

This tariff environment has catalyzed a shift toward nearshoring and localization of resin production. Contract manufacturing organizations and resin producers are establishing or expanding facilities in North America to mitigate levy exposure and streamline logistics. At the same time, strategic stockpiling of critical resin inventories has emerged as a risk-management tactic, ensuring uninterrupted supply for therapeutic production and research applications.

Despite these challenges, many market participants have leveraged tariff-driven cost pressures as an impetus for process optimization. Innovations in resin regeneration protocols and buffer recycling have offset some of the duty-induced expenses. Looking ahead, evolving trade policies and potential tariff renegotiations will continue to influence global sourcing decisions and pricing frameworks.

Unveiling Market Segmentation Patterns That Drive Growth

When examining market segmentation by type, agarose-based resins remain the cornerstone of high-capacity applications, while magnetic beads and monolithic columns are carving out niches in rapid screening and microfluidic platforms. Synthetic polymer matrices appeal to manufacturers seeking enhanced chemical and pH stability. In terms of application, the purification of monoclonal antibodies dominates demand, with diagnostic-grade and therapeutic-grade subsegments driving specialized resin formulations. Polyclonal antibody purification retains steady usage within research and diagnostic settings, whereas recombinant protein capture is expanding in vaccine and enzyme manufacturing.

End users span large pharmaceutical companies that leverage bulk resin for commercial production, contract manufacturing organizations focused on scalable service offerings, biotech firms pursuing early-stage development, and academic or research institutes conducting exploratory studies. The choice between bulk resin and prepacked columns hinges on process scale and automation requirements. Procurement channels vary from direct sales teams providing customized technical support to distributor networks and online sales platforms facilitating expedited ordering, particularly in emerging markets. Finally, purity tiers-analytical, clinical, and industrial grades-dictate resin cost structures and regulatory compliance pathways, with clinical-grade materials leading in therapeutic manufacturing and analytical-grade formats underpinning research-driven quality assessments.

Regional Variations Shaping Global Protein A Resin Demand

In the Americas, established biopharmaceutical hubs in the United States and Canada underscore robust demand for Protein A resins, buoyed by mature manufacturing infrastructures and sizable R&D investments. The market in Europe, Middle East & Africa benefits from regulatory harmonization efforts and a burgeoning biosimilars pipeline, with suppliers tailoring resin chemistries to comply with region-specific quality standards. Asia-Pacific stands out for its rapid expansion, as governmental support for biotech clusters in China, India, South Korea, and Japan accelerates adoption of advanced purification technologies.

Regional variances in healthcare funding models and scale of therapeutic production influence procurement strategies. North American organizations often prioritize long-term supply agreements and technical partnerships, while European entities balance cost pressures with sustainability mandates. In Asia-Pacific, local resin manufacturers are gaining footholds by aligning with national bioprocessing initiatives and offering price-competitive alternatives. These dynamics collectively shape competitive intensity, pricing models, and investment priorities across global Protein A resin markets.

Leading Players Steering the Future of Protein A Resin

The competitive landscape is anchored by a mix of global incumbents and agile specialists. Thermo Fisher Scientific has strengthened its offering through strategic acquisitions, integrating continuous chromatography systems and expanding buffer management solutions. Sartorius differentiates by embedding automation and digital monitoring into its resin portfolios, facilitating seamless integration with bioprocess control systems. Repligen focuses on high-performance ligands and co-development partnerships with contract development organizations to accelerate process validation.

Bio-Rad continues to leverage its well-established network and technical service capabilities to support regional growth initiatives, while Purolite Group emphasizes resin customization and expert consultation to address unique purification challenges. Emerging contenders and regional producers are contesting market share by offering localized manufacturing, expedited lead times, and cost-effective resin grades. Collaboration agreements and joint ventures between leading suppliers and biotechnology clusters further underscore the significance of strategic alliances in maintaining competitive advantage.

Strategic Imperatives to Thrive in a Shifting Resin Market

To thrive amid evolving market dynamics, industry leaders should prioritize supply chain diversification by establishing regional manufacturing footprints and multiple sourcing agreements. Advancing resin chemistries through targeted ligand modification and matrix innovation will enhance performance metrics and extend resin lifecycle, delivering cost efficiencies. Investing in continuous and single-use purification platforms can meet the demand for flexible, high-throughput processing models.

Forming strategic partnerships with contract development and manufacturing organizations can open new revenue streams and enhance technical support offerings. Embracing digital analytics for real-time resin performance monitoring will optimize process control and minimize unplanned downtime. Finally, articulating clear sustainability goals-such as reducing buffer consumption or adopting recyclable sorbents-will resonate with stakeholders and satisfy emerging environmental regulations, reinforcing brand credibility.

Rigorous Methodological Framework Underpinning the Analysis

This analysis is grounded in a multi-tiered research methodology combining primary and secondary data sources. Expert interviews with bioprocess engineers, procurement directors, and technical service leads provided qualitative insights into evolving purification requirements and supplier performance. Secondary research included peer-reviewed journals, regulatory filings, industry white papers, and corporate disclosures to validate market developments and historical trends.

Quantitative data was triangulated across multiple databases, ensuring consistency and accuracy in segmentation and regional breakdowns. A dedicated panel of regional specialists reviewed findings to account for local market dynamics and regulatory variances. Rigorous quality control protocols, including cross-referencing with validated case studies and benchmarking against public financial reports, underpin the analytical framework. This methodological rigor delivers a robust and transparent foundation for the insights presented.

Synthesis of Insights for Informed Decision Making

The Protein A resin market stands at a critical juncture, shaped by technological advances, shifting trade policies, and a diversifying therapeutic pipeline. Key segmentation insights underscore the importance of tailored resin formats, purity grades, and procurement channels in capturing market share. Regional analysis reveals distinct growth catalysts in the Americas, Europe, Middle East & Africa, and Asia-Pacific, underscoring the need for localized strategies.

Competitive intelligence highlights the significance of innovation, strategic alliances, and digital integration for maintaining leadership. Actionable recommendations provide a roadmap for optimizing supply chains, accelerating resin development, and aligning with sustainability objectives. Together, these insights equip stakeholders with the strategic perspective required to navigate complexity and capitalize on opportunities in the Protein A resin landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Agarose
    • Magnetic Bead
    • Monolithic
    • Synthetic Polymer
  • Application
    • Monoclonal Antibody Purification
      • Diagnostic
      • Therapeutic
    • Polyclonal Antibody Purification
    • Recombinant Protein Purification
  • End User
    • Biotech Companies
    • Contract Manufacturing Organizations
    • Pharmaceutical Companies
    • Research Institutes
  • Product Form
    • Bulk Resin
    • Prepacked Column
  • Distribution Channel
    • Direct Sales
    • Distributor Sales
    • Online Sales
  • Purity
    • Analytical Grade
    • Clinical Grade
    • Industrial Grade
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Cytiva
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Pall Corporation
  • Repligen Corporation
  • Purolite Co. Ltd.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Tosoh Bioscience LLC
  • BIA Separations d.o.o.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Protein a Resin Market, by Type
8.1. Introduction
8.2. Agarose
8.3. Magnetic Bead
8.4. Monolithic
8.5. Synthetic Polymer
9. Protein a Resin Market, by Application
9.1. Introduction
9.2. Monoclonal Antibody Purification
9.2.1. Diagnostic
9.2.2. Therapeutic
9.3. Polyclonal Antibody Purification
9.4. Recombinant Protein Purification
10. Protein a Resin Market, by End User
10.1. Introduction
10.2. Biotech Companies
10.3. Contract Manufacturing Organizations
10.4. Pharmaceutical Companies
10.5. Research Institutes
11. Protein a Resin Market, by Product Form
11.1. Introduction
11.2. Bulk Resin
11.3. Prepacked Column
12. Protein a Resin Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributor Sales
12.4. Online Sales
13. Protein a Resin Market, by Purity
13.1. Introduction
13.2. Analytical Grade
13.3. Clinical Grade
13.4. Industrial Grade
14. Americas Protein a Resin Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Protein a Resin Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Protein a Resin Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Cytiva
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Merck KGaA
17.3.4. Pall Corporation
17.3.5. Repligen Corporation
17.3.6. Purolite Co. Ltd.
17.3.7. Sartorius AG
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. Tosoh Bioscience LLC
17.3.10. BIA Separations d.o.o.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PROTEIN A RESIN MARKET MULTI-CURRENCY
FIGURE 2. PROTEIN A RESIN MARKET MULTI-LANGUAGE
FIGURE 3. PROTEIN A RESIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PROTEIN A RESIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PROTEIN A RESIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PROTEIN A RESIN MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PROTEIN A RESIN MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PROTEIN A RESIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PROTEIN A RESIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PURITY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PURITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PROTEIN A RESIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PROTEIN A RESIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PROTEIN A RESIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PROTEIN A RESIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROTEIN A RESIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PROTEIN A RESIN MARKET SIZE, BY AGAROSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PROTEIN A RESIN MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PROTEIN A RESIN MARKET SIZE, BY MONOLITHIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PROTEIN A RESIN MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PROTEIN A RESIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PROTEIN A RESIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PROTEIN A RESIN MARKET SIZE, BY POLYCLONAL ANTIBODY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PROTEIN A RESIN MARKET SIZE, BY RECOMBINANT PROTEIN PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PROTEIN A RESIN MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PROTEIN A RESIN MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PROTEIN A RESIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PROTEIN A RESIN MARKET SIZE, BY BULK RESIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PREPACKED COLUMN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PROTEIN A RESIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PROTEIN A RESIN MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PROTEIN A RESIN MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PROTEIN A RESIN MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PROTEIN A RESIN MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PROTEIN A RESIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. CANADA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 55. CANADA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CANADA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 62. MEXICO PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. MEXICO PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 93. GERMANY PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 98. GERMANY PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. GERMANY PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 100. FRANCE PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. FRANCE PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. FRANCE PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 103. FRANCE PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. FRANCE PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 105. FRANCE PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. FRANCE PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 114. ITALY PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. ITALY PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. ITALY PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 117. ITALY PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ITALY PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 119. ITALY PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. ITALY PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 121. SPAIN PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SPAIN PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SPAIN PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 126. SPAIN PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 149. DENMARK PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. DENMARK PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. DENMARK PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 152. DENMARK PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. DENMARK PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 154. DENMARK PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 163. QATAR PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. QATAR PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. QATAR PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 166. QATAR PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. QATAR PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 168. QATAR PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. QATAR PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 170. FINLAND PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FINLAND PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 175. FINLAND PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. FINLAND PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 191. EGYPT PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. EGYPT PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. EGYPT PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 196. EGYPT PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. EGYPT PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 198. TURKEY PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. TURKEY PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. TURKEY PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 201. TURKEY PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TURKEY PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 203. TURKEY PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. TURKEY PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 212. NORWAY PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NORWAY PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 217. NORWAY PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. NORWAY PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 219. POLAND PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. POLAND PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 222. POLAND PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 224. POLAND PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. POLAND PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC PROTEIN A RESIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 241. CHINA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. CHINA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. CHINA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 244. CHINA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. CHINA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 246. CHINA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. CHINA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 248. INDIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. INDIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. INDIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 251. INDIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 253. INDIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. INDIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 255. JAPAN PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. JAPAN PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 258. JAPAN PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. JAPAN PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 260. JAPAN PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. JAPAN PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 283. THAILAND PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. THAILAND PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. THAILAND PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 286. THAILAND PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 288. THAILAND PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. THAILAND PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN PROTEIN A RESIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN PROTEIN A RESIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN PROTEIN A RESIN MARKET SIZE, BY MONOCLONAL ANTIBODY PURIFICATION, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN PROTEIN A RESIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN PROTEIN A RESIN MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN PROTEIN A RESIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN PROTEIN A RESIN MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
TABLE 325. PROTEIN A RESIN MARKET SHARE, BY KEY PLAYER, 2024
TABLE 326. PROTEIN A RESIN MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Protein A Resin market report include:
  • Cytiva
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Pall Corporation
  • Repligen Corporation
  • Purolite Co. Ltd.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Tosoh Bioscience LLC
  • BIA Separations d.o.o.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.4 Billion
Compound Annual Growth Rate13.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Protein A Resin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Protein A Resin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 117 Pages
  • Global
From
Protein A Resins - Global Strategic Business Report - Product Image

Protein A Resins - Global Strategic Business Report

  • Report
  • 72 Pages
  • Global
From
Protein A Resin Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Protein A Resin Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 158 Pages
  • Global
From
Protein a Resin Market Report 2025 - Product Image

Protein a Resin Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Protein A Resin Market 2024-2028 - Product Image

Protein A Resin Market 2024-2028

  • Report
  • 145 Pages
  • Global
From

About the Protein A Resin Market

The Protein A Resin market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Protein A Resin is a type of resin used to purify and isolate antibodies from a sample. It is used in a variety of applications, including immunoprecipitation, affinity chromatography, and immunoassays. Protein A Resin is also used in the production of monoclonal antibodies, which are used in research and diagnostics. The Protein A Resin market is driven by the increasing demand for monoclonal antibodies in research and diagnostics. The growing demand for proteomics research and the increasing number of biopharmaceutical companies are also contributing to the growth of the market. Some of the major companies in the Protein A Resin market include Merck KGaA, Thermo Fisher Scientific, Bio-Rad Laboratories, GE Healthcare, and Sigma-Aldrich. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.